Obstetrics & Gynaecology Search
Obstetrics & Gynaecology Obstetrics & Gynaecology
leiomyomas
LEIOMYOMAS

Leiomyomas or uterine fibroids are benign tumors of the uterus that consist of smooth muscle and extracellular matrix collagen and elastin.

Most common solid pelvic tumors and one of the most frequent clinical conditions encountered in gynecologic practice.

They tend to grow during the reproductive years and usually regress during menopause.

 

Leiomyomas Management

Monitoring

  • Record location of palpable leiomyomas
  • Re-assess if new symptoms occur
  • Periodically repeat exams to ensure tumors are not growing rapidly
  • Medical preoperative therapy causes regression in the size of the fibroids so much so that in some cases, surgery may not be required  
  • As most fibroids decrease in size during menopause, asymptomatic patients may have expectant management
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Abemaciclib + fulvestrant survival benefit extends to Asians with HR+, HER- ABC
Pearl Toh, 12 Jan 2021
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.